More on ANNX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+29.4% Growth)
- Ratings (8.5 Score)

Upcoming Events

- Earnings (8/17/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Annexon (NQ:ANNX)
Delayed: 5.13 -0.09 (1.72%)
Prev. Close $5.22  
Open$5.30 
52 Wk High$ 
52 Wk Low$ 
Day High$5.40 
Day Low$5.13 
P/E N/A  
EPS$ 
Volume1,634,792 

Friends, Peers and Foes (?): ABBV, ABVX, APGE, BLTE, CNS (more...)

Jul 27, 2026 04:27 PM Form SCHEDULE 13G/A Annexon, Inc. Filed by: BlackRock, Inc.
Jul 21, 2026 03:46 AM Citizens Starts Annexon Biosciences (ANNX) at Market Underperform
Jul 20, 2026 06:50 AM H.C. Wainwright Reiterates Buy Rating on Annexon Biosciences (ANNX)
Jul 16, 2026 04:05 PM Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
Jul 15, 2026 04:20 PM Form 144 Annexon, Inc. Filed by: WIGGANS THOMAS G
Jul 15, 2026 07:27 AM Annexon Biosciences (ANNX) PT Raised to $25 at Needham
Jul 14, 2026 04:05 PM Annexon to present Phase 2 GA trial data at ASRS 2026 meeting
Jul 14, 2026 04:05 PM Annexon to Present Phase 2 ARCHER Baseline Characteristics Associated with Confirmed Best Corrected Visual Acuity 15-Letter Loss in Patients with Geographic Atrophy at ASRS 2026
Jul 14, 2026 01:57 PM Form 144 Annexon, Inc. Filed by: WIGGANS THOMAS G
Jul 13, 2026 07:39 AM Annexon Biosciences (ANNX) Reiterate at Overweight by Cantor Fitzgerald on Vonaprument
View All Articles

Entities mentioned with ANNX

View All Entities